This series of patient education fact sheets provides information on drugs used in the treatment of TB (e.g., Clofazimine, Ethambutol, Ethionamide, Isoniazid, Levofloxacin, Moxifloxacin, PASER [p-aminosalicylic acid granules], Pyrazinamide, Pyridoxine, Rifabutin, Rifampin, Streptomycin). The fact sheets include information on medication side effects, actions to take if side effects occur, and instructions in the event a dose of medication is missed.
Favorite
2017
This manual is a joint publication of the Curry International TB Center and the Tuberculosis Control Branch of the California Department of Public Health. The 10 chapters and 4 appendices cover major topics pertaining to epidemiology, diagnosis, laboratory issues, treatment, medications, pediatrics, co-morbidities and special situations, monitoring and case management, adverse reactions, and treatment of contacts.
Favorite
2016
This report analyses the factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. Detailed pricing profiles of key DR-TB drugs are also provided.
Favorite
International Agencies
Policy Makers
2016
This guide provides a summary of safety and efficacy data for drugs currently in use to treat TB. The guide also suggests advocacy points for activists, clinicians, and others working in TB.
Favorite
2016
This resource provides information and suggestions to support treatment adherence. The patient's healthcare provider for TB treatment can write in treatment details.
Favorite
Persons With LTBI
Persons with TB
2014
This resource provides information and general instructions for taking TB medicine. The patient's healthcare provider for TB treatment can write in treatment details.
Favorite
Persons With LTBI
Persons with TB
2014
This interim guidance provides advice on the inclusion of bedaquiline in the combination therapy of MDR-TB in accordance with the existing WHO Guidelines for the Programmatic Management of Drug-resistant TB (2011 Update).
Favorite
2013
This report highlights the issues surrounding high prices and poor supply of the drugs needed to treat drug-resistant tuberculosis (DR-TB). The report provides an overview of available drug-resistant TB medicines, including drug sources, quality status, and price.
Favorite
International Agencies
Policy Makers
2013
This fact sheet is intended as a convenient but not comprehensive reference for managing the care of HIV-infected patients with drug susceptible TB.
Favorite
2012
This fact sheet illustrates the timeline for various treatment regimens and monitoring techniques for persons with TB. It includes a timeline for drug regimens, providers, visits, sputum specimens, chest X-rays, and baseline and follow-up test.
Favorite
2012
The Tuberculosis Drug Information Guide, 2nd edition, is derived from Drug-Resistant Tuberculosis: A Survival Guide for Clinicians (2nd edition) produced in 2008. Two additional drugs, ofloxacin and clarithromycin (which are used primarily outside of the US), have been included. This Guide can help any physician, nurse, or pharmacist who participates in the management of patients with TB or LTBI.
Favorite
2012
This handbook has been prepared for school nurses who may be responsible for implementing tuberculin testing programs in their schools or working in collaboration with community providers in both the public and private sectors to manage the care of a child with tuberculosis (TB) disease or latent TB infection (LTBI)...
Favorite
2011
This slide set was developed as an accompaniment to Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection, a joint statement by CDC and the American Thoracic Society, and subsequent updates. The slide set provides an overview of the current recommendations for the treatment of latent tuberculosis...
Favorite
2011
This report highlights the issues surrounding high prices and poor supply of the drugs needed to treat drug-resistant tuberculosis (DR-TB). The report provides an overview of available drug-resistant TB medicines, including drug sources, quality status, and price.
Favorite
International Agencies
Policy Makers
2011
This information card provides information on the multiple significant drug interactions between TB medications; specifically, INH, rifampin, and other medications and the effect of the interaction. It also provides information on food interactions with TB drugs.
Favorite
Nurses
Outreach Workers
Physicians
2010
